Cancer Vaccine
The latest news about Cancer Vaccine: headlines, AI summaries and the full story from every source.
- Moderna Plans to Use Massachusetts Facility as Global Supply Hub for Cancer Vaccine
- Moderna Raises Full-Year Revenue Growth Outlook Following Third Quarter Earnings Beat
- Moderna Scheduled to Report Q3 Earnings Amid Valuation Debates and Cancer Vaccine Developments
- Moderna and Merck Face Manufacturing Challenges for Promising Personalized Cancer Vaccine
- Moderna Shares Decline Following William Blair Downgrade
- Moderna CEO Expresses Confidence in Personalized Cancer Vaccine Expansion Beyond Melanoma
- Moderna's mRNA Pipeline Expansion Drives Growth Potential Beyond COVID-19 Vaccines
- Moderna Stock Surges Amid Positive Cancer Vaccine News
- Moderna Stock Surges Over 550% Amid Cancer Vaccine Hype; Is It Too Late to Buy?
- Wall Street Analysts Remain Cautious on Moderna Stock Despite Recent Gains
- Moderna's Stock Rises on Strong Momentum from Cancer Vaccine Data
- Moderna's Cancer Vaccine Shows Promising Phase 3 Results
- Moderna's Stock Soars Over Fivefold This Year Amid Clinical Milestones
- Moderna Stock Falls After Sell Rating from Rothschild
- Rothschild & Co. Downgrades Moderna to Sell Amid Concern Over Stock Valuation
- Moderna's Recent Surge Amid Cancer Vaccine Trial Success
- Moderna Stock Surges 127% on Positive Cancer Vaccine Trial Results
- Merck's Personalized Cancer Vaccine Shows Success in Late-Stage Melanoma Trial
- Merck's Personalized Cancer Vaccine Shows Success in Late-Stage Melanoma Trial
- Stocks End Three-Day Losing Streak as Major Indexes Rise
- Moderna shares surge after positive cancer vaccine trial results
- Moderna Shares Surge on Positive Cancer Vaccine Trial Data
- Moderna and Merck Report Positive Results from mRNA Cancer Vaccine Trial